A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Su K. Metcalfe, MD, MPH, Michael T
Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
PUBLISH ONLY Journal of Thoracic Oncology
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
SC17.02 Lung Cancer in China: Challenges and Perspectives
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Cigarette Smoking Associated With Lung Adenocarcinoma In Situ in a Large Case- Control Study (SFBALCS)  Paige M. Bracci, PhD, Jennette Sison, MPH, Helen.
Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib  Sai-Hong Ignatius Ou, MD, PhD,
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Journal of Thoracic Oncology
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green 
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition  Sai-Hong.
Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD 
Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute  Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.
PUBLISH ONLY Journal of Thoracic Oncology
Imaging Requirements in the Practice of Pulmonary Metastasectomy
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis.
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
Heidi B. Rolke, Frode Gallefoss  Journal of Thoracic Oncology 
Journal of Thoracic Oncology
Mitotic Inhibitors Journal of Thoracic Oncology
P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma  Gustavo A. Lyons, Silvia Quadrelli,
MTP13-01: Indications and limitations of bronchoscopy
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Role of Postoperative Radiotherapy in Nonlocalized Thymoma
Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011)  Ellen.
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Immune-Modulating Vaccines in Non-small Cell Lung Cancer
Validation of the Proposed International Association for the Study of Lung Cancer Non- small Cell Lung Cancer Staging System Revisions for Advanced Bronchioloalveolar.
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases  Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
MTP19-01: T4 N0/N1 nonsmall cell lung cancer can be cured as a first line treatment with an expected five year survival rate as high as 43% provided a.
Ethnic Differences in the Management of Lung Cancer in New Zealand
Dan J. Raz, MD, Jason A. Zell, DO, MPH, Anthony N
Roger Hakimian, MD, Hongbin Fang, PhD, Leno Thomas, MD, Martin J
International Thymic Malignancies Interest Group: A Way Forward
European Lung Cancer Conference (ELCC) 2016 Organisation
OA Video-Assisted Thoracoscopic Surgery vs
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
IASLC 6th Latin American Conference on Lung Cancer
OA Survival Trends Among Non-Small Cell Lung Cancer (NSCLC) Patients Over A Decade: Impact of Initial Therapy at Academic Centers  B. Dholaria,
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Journal of Thoracic Oncology
Epidemiology of Thymoma and Associated Malignancies
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
A Review of First-Line Treatment for Small-cell Lung Cancer
Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD 
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Robert Comis, MD, The Passing of a “Lung Man”
Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.
Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases  Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy,
Presentation transcript:

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis at diagnosis  Jason A. Zell, Sai-Hong-Ignatius Ou, Argyrios Ziogas, Hoda Anton-Culver  Journal of Thoracic Oncology  Volume 2, Issue 8, Pages S314-S315 (August 2007) DOI: 10.1097/01.JTO.0000283102.62761.6d Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Overall survival for stage IIIB NSCLC, U.S. SEER data 1999-2003(n=7845). Journal of Thoracic Oncology 2007 2, S314-S315DOI: (10.1097/01.JTO.0000283102.62761.6d) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Overall survival for stage IV NSCLC, U.S. SEER data 1999-2003(n=19,590). Journal of Thoracic Oncology 2007 2, S314-S315DOI: (10.1097/01.JTO.0000283102.62761.6d) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions